Mylan Gets First-Ever GMP Warning Letter

 
• By Martin Berman-Gorvine

FDA’s GMP warning letter to Mylan cites failure to complete a required content uniformity test for generic Imodium manufactured at Puerto Rico plant.

More from United States

More from North America